• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Overview of Teplizumab for Delaying Onset and Progression of Type 1 Diabetes

Opinion
Video

Panelists discuss how teplizumab, the first FDA-approved disease-modifying therapy for Type 1 diabetes, can delay disease onset by targeting CD3+ T cells and preserving beta cell function in high-risk individuals.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease

Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease: GBD Analysis

Grace Halsey
September 10th 2025
Article

Nor does receiving a diabetes diagnosis guarantee optimal management as just one-fifth of people treated for the disease reached glycemic control in 2023.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial

Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial

Sydney Jennings
August 26th 2025
Article

Patients taking orforglipron achieved significant weight loss, hemoglobin A1c reduction, and cardiometabolic benefits in the phase 3 ATTAIN-2 study, supporting upcoming global regulatory submissions.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

Excess Intake of Ultraprocessed Foods Tied to Higher Cardiometabolic Risk: Daily Dose / image credit: ©New Africa/AdobeStock

Excess Intake of Ultraprocessed Foods Tied to Higher Cardiometabolic Risk: Daily Dose

Sydney Jennings
August 22nd 2025
Article

Your daily dose of the clinical news you may have missed.

Digital twin technology enables HbA1c reduction and medication tapering in primary care T2D management / image credit courtesy of Cleveland Clinic Kevin Pantalone, DO

Use of Digital Twin Technology Enabled Significant HbA1c Reduction and Medication Tapering in Primary Care T2D Management

Grace Halsey
August 21st 2025
Article

A Cleveland Clinic trial revealed that AI-driven precision treatment significantly reduced HbA1c and body weight, often eliminating need for medications other than metformin.

© 2025 MJH Life Sciences

All rights reserved.